← All trials
NCT07027566
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 25, 2025
- Primary completion
- May 31, 2026
- Completion date
- Jul 31, 2026
- First posted
- Jun 18, 2025
- Last posted
- Jun 18, 2025
- Enrollment
- 75
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Universidade Federal do ParaLead sponsor
- Universidade Federal do ParaSponsor investigator
- Universidade Federal do ParaOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.